Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
IL-12Rβ2 is essential for the development of experimental cerebral malaria.
Fauconnier M, Palomo J, Bourigault ML, Meme S, Szeremeta F, Beloeil JC, Danneels A, Charron S, Rihet P, Ryffel B, Quesniaux VF.
J Immunol. 2012 Feb 15;188(4):1905-14. Epub 2012 Jan 11.
Related citations
IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection.
Freitas do Rosário AP, Lamb T, Spence P, Stephens R, Lang A, Roers A, Muller W, O'Garra A, Langhorne J.
J Immunol. 2012 Feb 1;188(3):1178-90. Epub 2011 Dec 28.
Hepcidin is regulated during blood-stage malaria and plays a protective role in malaria infection.
Wang HZ, He YX, Yang CJ, Zhou W, Zou CG.
J Immunol. 2011 Dec 15;187(12):6410-6. Epub 2011 Nov 14.
B and T lymphocyte attenuator restricts the protective immune response against experimental malaria.
Adler G, Steeg C, Pfeffer K, Murphy TL, Murphy KM, Langhorne J, Jacobs T.
J Immunol. 2011 Nov 15;187(10):5310-9. Epub 2011 Oct 12. Erratum in: J Immunol. 2012 Jan 15;188(2):923.
Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection.
Villegas-Mendez A, de Souza JB, Murungi L, Hafalla JC, Shaw TN, Greig R, Riley EM, Couper KN.
J Immunol. 2011 Sep 15;187(6):2885-97. Epub 2011 Aug 31.
Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
Forbes EK, Biswas S, Collins KA, Gilbert SC, Hill AV, Draper SJ.
J Immunol. 2011 Oct 1;187(7):3738-50. Epub 2011 Aug 29.
CD8+ T effector memory cells protect against liver-stage malaria.
Reyes-Sandoval A, Wyllie DH, Bauza K, Milicic A, Forbes EK, Rollier CS, Hill AV.
J Immunol. 2011 Aug 1;187(3):1347-57. Epub 2011 Jun 29.
Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.
Malu DT, Bélanger B, Desautels F, Kelendji K, Dalko E, Sanchez-Dardon J, Leng L, Bucala R, Satoskar AR, Scorza T.
J Immunol. 2011 Jun 1;186(11):6271-9. Epub 2011 Apr 25.
Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.
Ramos TN, Darley MM, Hu X, Billker O, Rayner JC, Ahras M, Wohler JE, Barnum SR.
J Immunol. 2011 Jun 15;186(12):6657-60. Epub 2011 May 13.
Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria.
Haque A, Best SE, Unosson K, Amante FH, de Labastida F, Anstey NM, Karupiah G, Smyth MJ, Heath WR, Engwerda CR.
J Immunol. 2011 Jun 1;186(11):6148-56. Epub 2011 Apr 27.
Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization.
Schmidt NW, Harty JT.
J Immunol. 2011 Apr 1;186(7):3836-40. Epub 2011 Feb 28.
Filarial infection suppresses malaria-specific multifunctional Th1 and Th17 responses in malaria and filarial coinfections.
Metenou S, Dembele B, Konate S, Dolo H, Coulibaly YI, Diallo AA, Soumaoro L, Coulibaly ME, Coulibaly SY, Sanogo D, Doumbia SS, Traoré SF, Mahanty S, Klion A, Nutman TB.
J Immunol. 2011 Apr 15;186(8):4725-33. Epub 2011 Mar 16.
IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM.
J Immunol. 2011 Apr 15;186(8):4862-71. Epub 2011 Mar 9.
Human cord blood CD4+CD25hi regulatory T cells suppress prenatally acquired T cell responses to Plasmodium falciparum antigens.
Mackroth MS, Malhotra I, Mungai P, Koech D, Muchiri E, King CL.
J Immunol. 2011 Mar 1;186(5):2780-91. Epub 2011 Jan 28.
Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
Draper SJ, Biswas S, Spencer AJ, Remarque EJ, Capone S, Naddeo M, Dicks MD, Faber BW, de Cassan SC, Folgori A, Nicosia A, Gilbert SC, Hill AV.
J Immunol. 2010 Dec 15;185(12):7583-95. Epub 2010 Nov 22.
Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
Barfod L, Dobrilovic T, Magistrado P, Khunrae P, Viwami F, Bruun J, Dahlbäck M, Bernasconi NL, Fried M, John D, Duffy PE, Salanti A, Lanzavecchia A, Lim CT, Ndam NT, Higgins MK, Hviid L.
J Immunol. 2010 Dec 15;185(12):7553-61. Epub 2010 Nov 15.
Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammation.
Thévenon AD, Zhou JA, Megnekou R, Ako S, Leke RG, Taylor DW.
J Immunol. 2010 Dec 1;185(11):7115-22. Epub 2010 Oct 27.
Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria.
Reiling L, Richards JS, Fowkes FJ, Barry AE, Triglia T, Chokejindachai W, Michon P, Tavul L, Siba PM, Cowman AF, Mueller I, Beeson JG.
J Immunol. 2010 Nov 15;185(10):6157-67. Epub 2010 Oct 20.
Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting NF-kappaB signaling.
Labbé K, Miu J, Yeretssian G, Serghides L, Tam M, Finney CA, Erdman LK, Goulet ML, Kain KC, Stevenson MM, Saleh M.
J Immunol. 2010 Nov 1;185(9):5495-502. Epub 2010 Sep 27.
A complementary role for the tetraspanins CD37 and Tssc6 in cellular immunity.
Gartlan KH, Belz GT, Tarrant JM, Minigo G, Katsara M, Sheng KC, Sofi M, van Spriel AB, Apostolopoulos V, Plebanski M, Robb L, Wright MD.
J Immunol. 2010 Sep 15;185(6):3158-66. Epub 2010 Aug 13.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on